Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
142M
-
Number of holders
-
196
-
Total 13F shares, excl. options
-
129M
-
Shares change
-
+6.58M
-
Total reported value, excl. options
-
$1.23B
-
Value change
-
+$58.2M
-
Put/Call ratio
-
2.04
-
Number of buys
-
117
-
Number of sells
-
-83
-
Price
-
$9.52
Significant Holders of Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN) as of Q2 2025
235 filings reported holding DYN - Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q2 2025.
Dyne Therapeutics, Inc. - Common Stock, $0.0001 par value per share (DYN) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 129M shares
of 142M outstanding shares and own 90.71% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (9.71M shares), JANUS HENDERSON GROUP PLC (9.44M shares), Atlas Venture Life Science Advisors, LLC (9.13M shares), BlackRock, Inc. (8.08M shares), VANGUARD GROUP INC (7.65M shares), FCPM III SERVICES B.V. (5.46M shares), FMR LLC (5.29M shares), Siren, L.L.C. (4.84M shares), TCG Crossover Management, LLC (3.77M shares), and STATE STREET CORP (3.36M shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.